Citadel Advisors’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-208
Closed -$4.37K 13459
2025
Q1
$4.37K Buy
208
+194
+1,386% +$5.19K ﹤0.01% 13896
2024
Q4
$349 Buy
+14
New +$382 ﹤0.01% 14341
2024
Q3
Sell
-178
Closed -$5.01K 14583
2024
Q2
$5.01K Buy
178
+9
+5% +$936 ﹤0.01% 13436
2024
Q1
$50.7K Buy
169
+62
+58% +$18.5K ﹤0.01% 12162
2023
Q4
$25.3K Buy
+107
New +$16.6K ﹤0.01% 12419
2023
Q3
Sell
-123
Closed -$21.4K 14594
2023
Q2
$21.4K Sell
123
-67
-35% -$11.2K ﹤0.01% 12677
2023
Q1
$23.9K Buy
190
+184
+3,067% +$41.4K ﹤0.01% 12922
2022
Q4
$1.82K Buy
+6
New +$884 ﹤0.01% 14412
2022
Q1
Sell
-315
Closed -$45K 13963
2021
Q4
$45K Sell
315
-104
-25% -$18.9K ﹤0.01% 13305
2021
Q3
$92K Sell
419
-151
-26% -$32K ﹤0.01% 12959
2021
Q2
$132K Buy
570
+129
+29% +$32.8K ﹤0.01% 12647
2021
Q1
$133K Buy
441
+64
+17% +$22.9K ﹤0.01% 12182
2020
Q4
$142K Buy
377
+276
+273% +$96.7K ﹤0.01% 9985
2020
Q3
$31K Buy
+101
New +$38.6K ﹤0.01% 9749
2018
Q2
Sell
-140
Closed -$227K 8989
2018
Q1
$227K Buy
+140
New +$291K ﹤0.01% 7156

Other funds holding CBIO